Clinical Trials Logo

Autistic Behavior clinical trials

View clinical trials related to Autistic Behavior.

Filter by:
  • None
  • Page 1

NCT ID: NCT04100863 Recruiting - Clinical trials for Autism Spectrum Disorder

A Non-Interventional Pilot Study to Explore the Role of Gut Flora in Autism

Start date: March 2, 2020
Phase:
Study type: Observational [Patient Registry]

This study seeks to correlate microbiome sequencing data with information provided by patients and their medical records regarding autism.

NCT ID: NCT03829878 Withdrawn - Clinical trials for Autism Spectrum Disorder

Efficacy, Safety, and Tolerability Study of Oral Full-Spectrum MicrobiotaTM (CP101) in Subjects With Autism Spectrum Disorder and Associated GI Symptoms (SPROUT)

SPROUT
Start date: May 2020
Phase: Phase 2
Study type: Interventional

Adolescent autism spectrum disorder subjects with associated GI symptoms will be randomized to receive oral dosing of CP101 capsules in Treatment Group I or matching placebo capsules in Treatment Group II. The purpose of this study is to demonstrate the safety and effectiveness of CP101 in subjects with ASD and associated GI symptoms.

NCT ID: NCT03724136 Enrolling by invitation - Alzheimer Disease Clinical Trials

Alzheimer's Autism and Cognitive Impairment Stem Cell Treatment Study

ACIST
Start date: October 24, 2018
Phase: N/A
Study type: Interventional

The purpose of the study is to evaluate the use of autologous Bone Marrow Derived Stem Cells (BMSC) as a means to improve cognitive impairment as occurs in Alzheimer's Disease and other dementias and to improve behavior and socialization issues which occur in adult Autism Spectrum Disorder. The use of Near Infrared Light, in conjunction with the use of BMSC, will also be assessed.

NCT ID: NCT03206996 Completed - Clinical trials for Autism Spectrum Disorder

Exposure Therapy for Auditory Sensitivity in Autism

Start date: September 30, 2017
Phase: N/A
Study type: Interventional

Auditory hyper-reactivity affects up to 66% of children with autism spectrum disorder (ASD) and has been linked to greater stress and anxiety for children and their families. Exposure and Response Prevention (E/RP) is highly effective for reducing obsessive/compulsive behaviors in children with both OCD and ASD. This study is the first to assess the feasibility and efficacy of E/RP for auditory sensory hyper-reactivity in ASD.

NCT ID: NCT02677051 Active, not recruiting - Clinical trials for Autism Spectrum Disorder

Sulforaphane in a New Jersey (NJ) Population of Individuals With Autism

Start date: February 2016
Phase: Phase 2
Study type: Interventional

This study is a double blind treatment trial that will test if sulforaphane improves core symptoms in autism. The investigators expect to see clinical improvement in some of these areas. Sulforaphanes come from eating certain vegetables such as broccoli. The investigators will be using a preparation that gives specific and reproducible amounts. The investigators will also test specific chemicals and genes needed for sulforaphane usage to try to understand differences in response.